Skip to Content

LBA: Oral Vitamin C Supplementation for Patients with Early-Stage Myeloid Malignancies and Precursor Conditions Might Improve OS

Watch Stine Ulrik Mikkelsen from Rigshospitalet, Denmark, discuss her late-breaking abstract, which was just presented at the Late-Breaking Oral Session at EHA 2024. The study shows that there is significant potential for vitamin C supplementation to improve OS in patients with low-risk myeloid malignancies and precursor diseases.

Stine Ulrik Mikkelsen

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top